Researchers to study whether plasma of recovered patients can treat COVID-19Researchers from across Canada will collaborate on a vast clinical trial to study whether the plasma of recovered patients can be used to treat COVID-19. Controls can keep Canadian COVID-19 deaths under 44,000, health agency saysThe model for the best-case scenario suggests between 1% and 10% of the population will be infected Toronto researchers work on blood test to identify COVID-19 immunity Chlorthalidone not preferred over hydrochlorothiazide for hypertension treatment Study finds no difference in cardiovascular benefits, but greater risk of renal and electrolyte abnormalities with chlorthalidone Finance: if you're diversified don't hit the panic button Hydroxychloroquine for COVID-19 prevention or treatment lacks clinical evidence Pharmacy and medical organizations issue statements to discourage off-label prescribing Dire scenario for intensive care even if COVID-19 infection rate drops: study That scenario assumes the average daily rate of infections over 37 days would be 7.5% compared with the 26% daily rate that Canada has experienced recently Aerosol and fomite transmission SARS-CoV-2 is plausible NEJM: presence in aerosol of SARS-CoV-2 similar to that of CoV-1 Anterior hip replacement approach found to increase complications Different patterns of end-of-life care for Canadians of Chinese and South Asian ethnicity First Previous 108 109 110 111 112 Next Last